Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Seminoma | 3 | 2013 | 111 | 1.320 |
Why?
|
Calcium Carbonate | 2 | 2018 | 66 | 1.290 |
Why?
|
Testicular Neoplasms | 3 | 2013 | 751 | 0.900 |
Why?
|
Personnel Selection | 1 | 2021 | 195 | 0.720 |
Why?
|
Tumor Microenvironment | 4 | 2018 | 2987 | 0.650 |
Why?
|
Octamer Transcription Factor-3 | 2 | 2016 | 243 | 0.650 |
Why?
|
Nanoparticles | 2 | 2018 | 2048 | 0.550 |
Why?
|
Cancer Vaccines | 1 | 2022 | 1017 | 0.540 |
Why?
|
Endodermal Sinus Tumor | 1 | 2013 | 53 | 0.480 |
Why?
|
Neoplasms, Experimental | 2 | 2016 | 1338 | 0.480 |
Why?
|
Research | 1 | 2021 | 2009 | 0.450 |
Why?
|
Pneumonia, Viral | 5 | 2021 | 3275 | 0.430 |
Why?
|
Equipment and Supplies | 1 | 2014 | 295 | 0.430 |
Why?
|
Liver Transplantation | 1 | 2021 | 2022 | 0.400 |
Why?
|
Diagnostic Imaging | 2 | 2022 | 3495 | 0.400 |
Why?
|
Hospitals | 2 | 2022 | 3290 | 0.390 |
Why?
|
Viscera | 1 | 2010 | 149 | 0.390 |
Why?
|
Neoplasm Metastasis | 3 | 2018 | 5112 | 0.380 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3153 | 0.380 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2060 | 0.370 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4044 | 0.360 |
Why?
|
Catheter Ablation | 1 | 2021 | 2506 | 0.350 |
Why?
|
Students, Medical | 1 | 2021 | 1740 | 0.350 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2013 | 475 | 0.340 |
Why?
|
Radiology | 1 | 2021 | 1931 | 0.330 |
Why?
|
Radiology, Interventional | 2 | 2021 | 417 | 0.320 |
Why?
|
Thrombosis | 1 | 2020 | 2840 | 0.310 |
Why?
|
Microwaves | 3 | 2022 | 173 | 0.300 |
Why?
|
Pandemics | 5 | 2021 | 7089 | 0.290 |
Why?
|
Fibroblasts | 1 | 2016 | 4299 | 0.280 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2016 | 2635 | 0.260 |
Why?
|
Cell Lineage | 1 | 2013 | 2630 | 0.250 |
Why?
|
Mice, Nude | 5 | 2020 | 3859 | 0.250 |
Why?
|
Infection Control | 2 | 2021 | 959 | 0.240 |
Why?
|
Early Detection of Cancer | 3 | 2022 | 2865 | 0.240 |
Why?
|
Particle Size | 2 | 2018 | 1715 | 0.230 |
Why?
|
Cryptogenic Organizing Pneumonia | 1 | 2021 | 30 | 0.210 |
Why?
|
Internship and Residency | 1 | 2021 | 5556 | 0.210 |
Why?
|
Blood Group Antigens | 1 | 2022 | 171 | 0.200 |
Why?
|
Technology | 1 | 2022 | 237 | 0.200 |
Why?
|
Peripheral Arterial Disease | 2 | 2022 | 1206 | 0.200 |
Why?
|
Annexin A2 | 1 | 2020 | 44 | 0.200 |
Why?
|
Search Engine | 1 | 2021 | 136 | 0.190 |
Why?
|
Information Seeking Behavior | 1 | 2021 | 128 | 0.190 |
Why?
|
Stem Cells | 1 | 2013 | 3593 | 0.190 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2022 | 761 | 0.170 |
Why?
|
Neoplasms | 3 | 2022 | 20172 | 0.170 |
Why?
|
Human Rights | 1 | 2021 | 275 | 0.170 |
Why?
|
Thoracic Wall | 1 | 2019 | 193 | 0.170 |
Why?
|
Awards and Prizes | 1 | 2022 | 345 | 0.170 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 954 | 0.160 |
Why?
|
Fibrosarcoma | 1 | 2018 | 341 | 0.150 |
Why?
|
Radiology Department, Hospital | 1 | 2021 | 413 | 0.150 |
Why?
|
Radiography, Thoracic | 2 | 2021 | 1344 | 0.150 |
Why?
|
Dogs | 1 | 2021 | 4059 | 0.150 |
Why?
|
Acids | 1 | 2016 | 136 | 0.150 |
Why?
|
Cryosurgery | 1 | 2019 | 408 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 5 | 2022 | 20308 | 0.140 |
Why?
|
Cell Line, Tumor | 5 | 2020 | 16959 | 0.140 |
Why?
|
Information Storage and Retrieval | 1 | 2021 | 826 | 0.140 |
Why?
|
Renal Insufficiency | 1 | 2020 | 792 | 0.140 |
Why?
|
Telephone | 1 | 2018 | 624 | 0.140 |
Why?
|
Technology Transfer | 1 | 2014 | 43 | 0.140 |
Why?
|
Lung | 4 | 2022 | 9706 | 0.130 |
Why?
|
Intellectual Property | 1 | 2014 | 47 | 0.130 |
Why?
|
Retrospective Studies | 13 | 2022 | 71483 | 0.130 |
Why?
|
Pleural Neoplasms | 1 | 2019 | 600 | 0.130 |
Why?
|
Stromal Cells | 2 | 2020 | 1361 | 0.130 |
Why?
|
Humans | 32 | 2022 | 708843 | 0.130 |
Why?
|
Vision, Binocular | 1 | 2015 | 192 | 0.130 |
Why?
|
Abdomen | 1 | 2020 | 1094 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 8877 | 0.120 |
Why?
|
Radiography, Interventional | 1 | 2021 | 1096 | 0.120 |
Why?
|
Mice, Inbred BALB C | 3 | 2020 | 6684 | 0.120 |
Why?
|
alpha-Fetoproteins | 1 | 2013 | 217 | 0.120 |
Why?
|
Self Care | 1 | 2018 | 799 | 0.120 |
Why?
|
Immunologic Factors | 1 | 2022 | 1578 | 0.120 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 1148 | 0.110 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2013 | 349 | 0.110 |
Why?
|
Tissue Array Analysis | 1 | 2013 | 580 | 0.110 |
Why?
|
Glutathione Transferase | 1 | 2013 | 591 | 0.110 |
Why?
|
Neuroendocrine Tumors | 1 | 2016 | 534 | 0.100 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2015 | 654 | 0.100 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2010 | 76 | 0.100 |
Why?
|
Influenza, Human | 1 | 2021 | 1344 | 0.100 |
Why?
|
Green Fluorescent Proteins | 1 | 2016 | 2193 | 0.100 |
Why?
|
Small Molecule Libraries | 1 | 2015 | 732 | 0.090 |
Why?
|
Patient Discharge | 1 | 2022 | 2980 | 0.090 |
Why?
|
Sialoglycoproteins | 1 | 2010 | 370 | 0.090 |
Why?
|
Lung Neoplasms | 3 | 2022 | 12183 | 0.090 |
Why?
|
Animals | 7 | 2021 | 170486 | 0.080 |
Why?
|
Cell Survival | 1 | 2018 | 6156 | 0.080 |
Why?
|
Immunohistochemistry | 2 | 2013 | 11790 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3714 | 0.080 |
Why?
|
Endovascular Procedures | 1 | 2020 | 1959 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2022 | 2910 | 0.080 |
Why?
|
Proteoglycans | 1 | 2010 | 831 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2579 | 0.080 |
Why?
|
Immunotherapy | 1 | 2022 | 4057 | 0.080 |
Why?
|
Calcium | 1 | 2020 | 5825 | 0.080 |
Why?
|
Attitude of Health Personnel | 1 | 2021 | 3885 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2010 | 796 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2022 | 3970 | 0.070 |
Why?
|
Antigens, Surface | 1 | 2010 | 1858 | 0.070 |
Why?
|
Kidney | 1 | 2020 | 6888 | 0.070 |
Why?
|
Palliative Care | 1 | 2019 | 3261 | 0.070 |
Why?
|
Male | 13 | 2022 | 349524 | 0.070 |
Why?
|
Mice | 5 | 2020 | 80876 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2016 | 2968 | 0.070 |
Why?
|
Pain | 1 | 2019 | 4636 | 0.070 |
Why?
|
Middle Aged | 10 | 2022 | 213752 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2021 | 61932 | 0.060 |
Why?
|
Glucose | 1 | 2016 | 4261 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3014 | 0.060 |
Why?
|
Massachusetts | 3 | 2021 | 8712 | 0.060 |
Why?
|
Telemedicine | 1 | 2018 | 2583 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 39292 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13714 | 0.050 |
Why?
|
Career Mobility | 1 | 2022 | 263 | 0.050 |
Why?
|
Cells, Cultured | 1 | 2016 | 20170 | 0.050 |
Why?
|
Cholecystectomy | 1 | 2021 | 386 | 0.050 |
Why?
|
Urban Health Services | 1 | 2020 | 182 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39038 | 0.050 |
Why?
|
Retreatment | 1 | 2020 | 628 | 0.050 |
Why?
|
Perfusion Imaging | 1 | 2020 | 189 | 0.040 |
Why?
|
Societies, Medical | 2 | 2021 | 3776 | 0.040 |
Why?
|
Aged | 7 | 2022 | 161488 | 0.040 |
Why?
|
Hepatectomy | 1 | 2021 | 561 | 0.040 |
Why?
|
Vaginal Smears | 1 | 2021 | 498 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 445 | 0.040 |
Why?
|
Laparotomy | 1 | 2020 | 472 | 0.040 |
Why?
|
Female | 10 | 2022 | 375205 | 0.040 |
Why?
|
Pilot Projects | 1 | 2010 | 7994 | 0.040 |
Why?
|
North America | 1 | 2020 | 1174 | 0.040 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 1 | 2020 | 199 | 0.040 |
Why?
|
Niclosamide | 1 | 2016 | 4 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2020 | 572 | 0.040 |
Why?
|
Policy Making | 1 | 2021 | 533 | 0.040 |
Why?
|
Nephrectomy | 1 | 2022 | 993 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2013 | 11718 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2021 | 19800 | 0.030 |
Why?
|
Proteins | 1 | 2010 | 6151 | 0.030 |
Why?
|
Observer Variation | 1 | 2021 | 2687 | 0.030 |
Why?
|
Indocyanine Green | 1 | 2015 | 211 | 0.030 |
Why?
|
Lower Extremity | 1 | 2022 | 1041 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2016 | 489 | 0.030 |
Why?
|
Program Development | 1 | 2020 | 1328 | 0.030 |
Why?
|
Young Adult | 3 | 2020 | 55940 | 0.030 |
Why?
|
Colonoscopy | 1 | 2021 | 1335 | 0.030 |
Why?
|
Vascular Surgical Procedures | 1 | 2022 | 1510 | 0.030 |
Why?
|
Fluorescence | 1 | 2015 | 774 | 0.030 |
Why?
|
Prognosis | 1 | 2013 | 28919 | 0.030 |
Why?
|
Glycolysis | 1 | 2016 | 815 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2020 | 2427 | 0.030 |
Why?
|
Program Evaluation | 1 | 2020 | 2524 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2020 | 4310 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2015 | 725 | 0.020 |
Why?
|
Hospitalization | 2 | 2020 | 9644 | 0.020 |
Why?
|
Mammography | 1 | 2021 | 2442 | 0.020 |
Why?
|
Pain Measurement | 1 | 2019 | 3510 | 0.020 |
Why?
|
United States | 3 | 2022 | 67165 | 0.020 |
Why?
|
Adult | 4 | 2020 | 211041 | 0.020 |
Why?
|
Radiography | 1 | 2020 | 6989 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8720 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 41038 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1977 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3244 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 13274 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7763 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5784 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58184 | 0.020 |
Why?
|
Risk Factors | 2 | 2022 | 69553 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3308 | 0.020 |
Why?
|
Apoptosis | 1 | 2020 | 10085 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 4930 | 0.010 |
Why?
|
Mitochondria | 1 | 2016 | 3665 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 16008 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22989 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18375 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2022 | 15053 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23284 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 11594 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 84718 | 0.010 |
Why?
|
Concepts
(183)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(63)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_